Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2005
03/09/2005CN1192098C Bio-active substance of antrodia camphorata mycelia, its preparing process and its composition
03/09/2005CN1192035C Inhibitors of interleukin-1'beta' converting enzyme
03/09/2005CN1192021C 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands
03/09/2005CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
03/09/2005CN1192015C Cell adhesion inhibitors
03/09/2005CN1191861C Medicinal compositions containing anti-Fas antibody
03/09/2005CN1191860C Method for treatment of fibrosis using antagonist of integrin alpha-4 subunit
03/09/2005CN1191854C Model membrane systems
03/09/2005CN1191853C Preparations containing virus-like particles as immunopotentiators administered through mucosa
03/09/2005CN1191852C Vaccine
03/08/2005US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents
03/08/2005US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
03/08/2005US6864355 Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
03/08/2005US6864291 Agonists specific for the peripheral cannabinoid receptor
03/08/2005US6864277 Brain diosrders; cardiovascular disorders; central nervous system disorders; psychological disorders
03/08/2005US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
03/08/2005US6864252 Treatment of cyclooxygenase mediated diseases, such as arthritis, neurodegeneration and colon cancer
03/08/2005US6864250 N-acylated lipophilic amino acid derivatives
03/08/2005US6863901 Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
03/08/2005US6863893 Vaccination of mammals with pneumococcal derived polypeptides that include an alpha helix but exclude a choline binding region as a mechanism for stimulating production of an antibody that protects vaccine recipient from infection
03/08/2005US6863647 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
03/08/2005CA2480712A1 Chondrocyte therapeutic delivery system
03/08/2005CA2446562C Pharmaceutical formulation of fluticasone propionate
03/03/2005WO2005019450A1 Process for producing cytotoxic lymphocytes
03/03/2005WO2005019245A1 Heptadepsin
03/03/2005WO2005019219A1 Pyrrolopyrimidinone derivative
03/03/2005WO2005019218A1 Pyrrolopyrimidinethione derivative
03/03/2005WO2005019203A1 Haloalkyl- and piperidine-substituted benzimidazole-derivatives
03/03/2005WO2005019182A1 Pyrazolylmethylbenzamide derivatives as p2xt-receptor antagonists
03/03/2005WO2005019175A1 Fexofenadine polymorphs and processes of preparing the same
03/03/2005WO2005018675A1 Therapeutic agent for autoimmune disease
03/03/2005WO2005018663A1 G-csf derivative for inducing immunological tolerance
03/03/2005WO2005018648A1 (20S)-1α-HYDROXY-2-METHYLENE-19-NOR-VITAMIN D3 AND ITS USES
03/03/2005WO2005018610A1 In vivo targeting of dendritic cells
03/03/2005WO2005018556A2 Hydroxylamine substituted imidazo-containing compounds
03/03/2005WO2005018551A2 Oxime substituted imidazo-containing compounds
03/03/2005WO2004012766A8 Method for correcting immune responses and medicinal agent
03/03/2005US20050049424 6-Hydroxy isoflavones derivatives and medicaments involving same
03/03/2005US20050049303 Adamantane derivatives
03/03/2005US20050049292 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
03/03/2005US20050049271 Solubility, dissolution rate and bioavailability; X-ray diffraction peak pattern comprising broad halo at 2 theta of about 17 degrees
03/03/2005US20050049263 Purine analogs having hsp90-inhibiting activity
03/03/2005US20050049258 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease
03/03/2005US20050049251 Inhibitors of p38
03/03/2005US20050049246 Such as [3-(2-Bromo-ethoxy)-phenyl]-[4-(3-cyclohexyl-5-methyl-isoxazol-4-yl)-pyrimidin-2-yl]-amine
03/03/2005US20050049216 Immunostimulatory nucleic acid molecules
03/03/2005US20050049215 contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulating interferon-alpha to treat viral infections; oligonucleotide linked to a biodegradable delivery complex
03/03/2005US20050049205 Product from rose hips e.g. 3- beta -D-galactopyranosyloxy-2-(octadeca-9Z,12Z,15Z-trienoyloxy)propanyl octadeca-9Z,12Z,15Z-trienoate (GOPO); arthritis and osteoarthritis
03/03/2005US20050049202 For treating disorders associated with excessive cytokine release such as interleukin-1 (IL-1) for example infection, cancer, asthma, coronary restenosis, autoimmune disease, cirrhosis, entotoxemia, reperfusion injury and septic shock; lactone or lactam-benzoates or benzamides
03/03/2005US20050049191 Administering TA1 peptide by infusion so as to continuously maintain an immune stimulating-effective amount of the peptide in the patient during a treatment period of at least about 6 hours
03/03/2005US20050049190 Cation conducting gabaa receptors and their use
03/03/2005US20050049189 Immunosuppressive protein for use in treatment and prevention of allergic, autoimmune, skin and respiratory disorders
03/03/2005US20050048639 Caspase-8 binding protein, its preparation and use
03/03/2005US20050048632 Novel DNA encoding Eimeria glyceroaldehyde-3-phosphate dehydrogenase and uses thereof
03/03/2005US20050048478 Preparing agents which prevent and/or treat viral diseases; immunotherapy; mimetics
03/03/2005US20050048104 Transdermal drug delivery devices comprising a polyurethane drug reservoir
03/03/2005US20050048081 Immunogenic compositions comprising DAL/DAT double mutant, auxotrophic attenuated strains of listeria and their mehods of use
03/03/2005US20050048079 Induction response in cells; joining to adenosine triphosphate binding domain; therapy for Aids; anticancer agents
03/03/2005US20050048067 Antiproliferative agents; therapy for autoimmune disease
03/03/2005US20050048066 Identification of potential immunodominant acetylcholine receptor alpha subunit
03/03/2005US20050048054 Lymphocytes; methods
03/03/2005US20050048053 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications
03/03/2005US20050048052 Bioassay for detecting expression of mammalian CC-chemokine receptor 2, by binding of antibody or antigen-binding fragment; human or humanized monoclonal antibody; test kits
03/03/2005US20050048035 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
03/03/2005US20050048034 Using adipose stem cells to treat ischemic ulcer, diabetic and traumatic wounds; regenerative medicine
03/03/2005US20050048029 Nucleotide sequence for diagnosis, prevention, therapy of cancer, inflammation, autoimmune disease and infections
03/03/2005US20050048026 Remedies for ischemic diseases
03/03/2005US20050048024 Compounds for use as surfactants
03/03/2005CA2816222A1 Influenza hemagglutinin and neuraminidase variants
03/03/2005CA2537257A1 Fexofenadine polymorphs and processes of preparing the same
03/03/2005CA2536492A1 Process for producing cytotoxic lymphocytes
03/03/2005CA2536152A1 G-csf derivative for inducing immunological tolerance
03/03/2005CA2535120A1 Hydroxylamine substituted imidazo-containing compounds
03/03/2005CA2535117A1 Oxime substituted imidazo-containing compounds
03/02/2005EP1510518A2 Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha levels
03/02/2005EP1510516A1 Pyrazole compound and medicinal composition containing the same
03/02/2005EP1510219A1 Method for identifying at least one Aminopeptidase-inhibitor
03/02/2005EP1510217A1 An anti-rheumatism medicament and method to prepare thereof
03/02/2005EP1510210A1 Immunity-related protein kinase inhibitors
03/02/2005EP1509621A1 Treatment with cytokines for alzheimer's disease
03/02/2005EP1509618A2 Autoimmune conditions and nadph oxidase defects
03/02/2005EP1509606A1 Allergen from mugwort pollen
03/02/2005EP1509543A2 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus
03/02/2005EP1509526A2 Imidazo(1,2-a)pyrazin-8-ylamines, method of making, and method of use thereof
03/02/2005EP1509524A1 Xanthine phosphodiesterase v inhibitor polymorphs
03/02/2005EP1509515A2 Substituted 4-aryl-4h-pyrrolo 2,3-h chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
03/02/2005EP1509506A1 Pyridazine derivatives
03/02/2005EP1509499A1 Pyrrole compounds for the treatment of prostaglandin mediated diseases
03/02/2005EP1509498A1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
03/02/2005EP1509489A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
03/02/2005EP1509251A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
03/02/2005EP1509241A1 Novel uses of cephaibols
03/02/2005EP1509237A2 Methods of treating angiogenesis, tumor growth, and metastasis
03/02/2005EP1509235A1 Method for the protection of endothelial and epithelial cells during chemotherapy
03/02/2005EP1509233A1 Liquid formulation of decitabine and use of the same
03/02/2005EP1509223A1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin
03/02/2005EP1509188A2 Compounds active at the glucocorticoid receptor ii
03/02/2005EP1509086A2 Htlv-i tax induced killing of p53 null cancer cells
03/02/2005EP1421115B1 Soluble t cell receptor
03/02/2005EP1384476B1 Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases
1 ... 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 ... 1172